Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient stored Vivotif vaccine at room temperature while was taking; The patient stored Vivotif vaccine at room temperature while taking it; Case reference number US-BN-2024-002772 is a spontaneous case initially received from a pharmacist via Med Communications (reference number: USBAV24-2994) on 12-Nov-2024 and concerns a patient of unknown gender and unknown age. The patient's medical history and concomitant medications were not provided. On an unspecified date, the patient stored Vivotif vaccine at room temperature (explicitly coded as 'product storage error'). On an unspecified date, the patient took a dose of affected Vivotif, (batch number: unknown) unknown dose, unknows site of administration, unknown route for unknown indication (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20241112-43115b to US-BAVARIAN NORDIC A/S-US-BN-2024-002772, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A patient of unknown gender and age took a dose of affected Vivotif which was stored at room temperature, for unknown indication, which is considered as product administration error and product storage error. It was unknown if the patient experienced any adverse event due to Vivotif. Product storage error and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error and product administration error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown gender and age took a dose of affected Vivotif which was stored at room temperature, for unknown indication, which is considered as product administration error and product storage error. It was unknown if the patient experienced any adverse event due to Vivotif. Product storage error and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error and product administration error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.